Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New York, New York 10016


Purpose:

This clinical study was to evaluate the control of dental plaque formation after toothbrushing for 4 days with each of the 4 study toothpastes.


Study summary:

Evaluation of dental plaque control for two prototype toothpastes will be determined by comparison to two control toothpastes.


Criteria:

Inclusion Criteria: - Male or female volunteers at least 18 - 53 years of age - Good general health - Must sign informed consent form - Minimum of 20 natural uncrowned teeth (excluding third molars) must be present. - No history of allergy to personal care consumer products, or their ingredients, relevant to any ingredient in the test products as determined by the dental/medical professional monitoring the study. Exclusion Criteria: - Subjects unable or unwilling to sign the informed consent form. - Medical condition which requires pre-medication prior to dental visits/procedures - Moderate or advanced periodontal disease or heavy dental tartar (calculus). - 2 or more decayed untreated dental sites at screening. - Other disease of the hard or soft oral tissues. - Impaired salivary function (e.g. Sjogren's syndrome or head and neck irradiation). - Use of medications that are currently affecting salivary function - Use of antibiotics or antimicrobial drugs within 30 days prior to study visit #1. - Pregnant or nursing women. - Participation in any other clinical study within 1 week prior to enrollment into this study. - Use of tobacco products - Subjects who must receive dental treatment during the study dates. - Current use of Antibiotics for any purpose. - Presence of an orthodontic appliance which interferes with plaque scoring. - History of allergy to common dentifrice ingredients. - History of allergy to arginine (amino acid) - History of allergy to bicarbonate - Immune compromised individuals (HIV, AIDS, immuno suppressive drug therapy)


NCT ID:

NCT00758394


Primary Contact:

Principal Investigator
Patricia Corby, DDS


Backup Contact:

N/A


Location Contact:

New York, New York 10016
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.